Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.
about
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease.Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.Cell-permeable protein therapy for complex I dysfunctionCharacteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism.Mitochondrial disease: genetics and management.Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adultsA recurrent mitochondrial p.Trp22Arg NDUFB3 variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype.Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.Expert consensus document: Mitochondrial function as a therapeutic target in heart failureDiagnostic approach and differential diagnosis in patients with hypertrophied left ventricles.Pregnancy, cardiomyopathies, and genetics.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Mitochondrial Mutations in Cardiac Disorders.MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.Management of pregnancy in cardiomyopathies and heart failure.Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function.Mitochondrial disease heterogeneity: a prognostic challenge.Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice.tURn the lights on: mitochondrial transport-RNAs and cardiovascular disease.Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders.Myocardial Layer-Specific Strain Analysis in Children with Mitochondrial Disease.Understanding mitochondrial disease and goals for its treatment.Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure.Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy.Pediatric Cardiomyopathies.Hypertrophic cardiomyopathy in mitochondrial disorders: description of an uncommon clinical case.Study of respiratory chain dysfunction in heart disease.
P2860
Q31165571-10C96C5D-3786-4AD9-A2BA-149A3C6D44B0Q35552917-CF4BEA63-C431-4437-A316-10A4592CD39CQ35660914-4DAAA00C-3EAB-4527-9414-141DC76DD805Q35814768-361B8D4F-FDAA-42A3-B422-893E85795EF9Q35825296-73F729B4-6B8B-4A86-B95C-21A5B13AE36AQ36492283-D7287B32-FE8B-4C86-800C-28DE4CBF3924Q37225729-2859FE86-4FEB-4962-BD01-2EDDA1FCA651Q37235772-346C0ACA-5254-4565-B56A-ED42A3170B4EQ37285513-343F8F79-C7C0-43D4-B022-2E13FAC0F677Q37699474-1D30A37E-9051-4422-8AEB-E7534106CB0BQ38103225-0B70F8DB-FCD5-42E9-BAFD-998887081D6BQ38180838-C55146B7-D03E-4EF3-B0E3-9AFBDC4CF4C8Q38343713-94BCFCAA-D713-48F8-939B-12DDF26AE52CQ38678063-C9D8D9CC-B075-4441-A7B3-8545AEBC4239Q38681881-13CABF56-AF18-4911-9CEF-3A2C87605F01Q38780993-9CEE7F8A-C2C1-4DB2-8C23-F82FBF03C6D2Q39232047-B74958ED-F9BA-4EE4-AFDC-8377E0ABEC9AQ39390119-E64F9FBF-F02D-4375-8C2B-8775FAB04528Q41935727-D913F466-33E6-460E-8F10-56D1C1BFA601Q42111597-6B375647-A7F5-46B7-B1A8-5CE72822F0AAQ42202731-1FE45A54-FC54-4606-BB36-F73795329DFFQ42406341-FD64ED34-FBBA-4B65-BAEC-1825851F2D59Q43946370-49956AB6-3900-476F-AD9B-F85E0FBECC72Q46755952-DA66F146-0FB5-4148-9078-02ABDABF6FAAQ47098986-FF1C5DB4-311D-4574-A162-01D25F8F5BDFQ47902068-64974E25-08D1-4369-9E84-3F39646DF44DQ48137958-6862ECEE-DFC2-42A4-BC45-4C637FFF5556Q49886497-EA7C99ED-78EC-4FE9-BE12-DD18E1369B00Q50548852-02EAB3A1-888B-48BD-A36B-8C225CC56629Q51352445-A957A61F-84AF-4358-B6DE-7A26151F50C1Q54099566-0155C388-6044-4DFC-B8D0-353B3D205C2AQ55088026-19DEF02B-98E1-4D99-8967-DDE255054805
P2860
Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@ast
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@en
type
label
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@ast
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@en
prefLabel
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@ast
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@en
P2093
P2860
P921
P356
P1476
Cardiac involvement in mitocho ...... um, diagnosis, and management.
@en
P2093
Carla Giordano
Douglass M Turnbull
Giulia d'Amati
John P Bourke
Matthew G D Bates
Robert W Taylor
P2860
P304
P356
10.1093/EURHEARTJ/EHS275
P5008
P577
2012-08-30T00:00:00Z
2012-12-01T00:00:00Z